Recent Updates
Recently added Catalysts
LMAT Positive Sentiment Score: 75/100

LeMaitre to Participate at Upcoming Investor Conferences in March

Friday, March 3, 2023 2 min read
Key Takeaway: LeMaitre Vascular, Inc. will participate in four investor conferences in March, showcasing their commitment to engaging the investment community. Key executives, including President David Roberts and CFO JJ Pellegrino, will present at various prestigious events, indicating confidence in the company's strategic direction. LeMaitre specializes in medical devices for peripheral vascular disease, addressing a significant health concern affecting millions worldwide.

Market Sentiment Analysis

POSITIVE FACTORS

  • LeMaitre Vascular is actively engaging with investors through multiple conferences.
  • Participation in reputable healthcare conferences highlights confidence in their business strategy.
  • The company addresses a significant global health issue with its vascular devices.
  • Management's presence at these conferences demonstrates a commitment to transparency and growth.

Full Press Release Details

BURLINGTON, Mass., March 03, 2023 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in four upcoming investor conferences in March.
35th Annual Roth Conference 2023
Monday, March 13, 2023
The Ritz Carlton, Laguna Niguel located in Dana Point, CA
David Roberts, President, will participate in a fireside chat at 12:30 PM PT (3:30 PM ET)
Oppenheimer 33rd Annual Healthcare Conference (Virtual)
Wednesday, March 15, 2023
JJ Pellegrino, Chief Financial Officer, will present at 8:40 AM ET
Barclays Global Healthcare Conference
Wednesday, March 15, 2023
Loews Miami Beach Hotel, Miami Beach, FL
David Roberts, President, will present at 2:35 PM ET
KeyBanc Life Sciences & MedTech Investor Forum (Virtual)
Wednesday, March 22, 2023
David Roberts, President, will present at 3:00 PM ET
LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. The Company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. Additional information can be found at www.lemaitre.com.

Tags

Frequently Asked Questions

What investor conferences will LeMaitre attend in March 2023?

LeMaitre Vascular will attend four investor conferences in March 2023.

Who will speak at the Roth Conference on March 13, 2023?

David Roberts, President of LeMaitre, will participate in a fireside chat.

When is the Oppenheimer Healthcare Conference?

The Oppenheimer Conference is on March 15, 2023, at 8:40 AM ET.

What is LeMaitre Vascular known for?

LeMaitre specializes in devices and services for treating peripheral vascular disease.

How many people are affected by peripheral vascular disease globally?

Over 200 million people worldwide are affected by peripheral vascular disease.

Tags: LMAT Viatris Investor Conferences Healthcare LeMaitre Vascular investor conferences vascular disease healthcare
Last updated: Mar 3, 2023